End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B.

scientific article

End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/1096-9071(200007)61:3<403::AID-JMV21>3.0.CO;2-5
P698PubMed publication ID10861654

P2093author name stringKeeffe EB
P2860cites workThe anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineQ28327158
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunizationQ30468279
Interferon in the management of chronic hepatitis B.Q40891677
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulinQ42540557
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.Q42541246
Liver transplantation in Asian patients with chronic hepatitis B.Q44675890
Lamivudine treatment for acute hepatitis B after liver transplantationQ44704413
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantationQ45754826
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot studyQ45759880
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxisQ45761265
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.Q46990265
Short-term cyclosporine induces a remission of autoimmune hepatitis in children.Q53347844
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.Q53933482
P433issue3
P921main subjectlamivudineQ422631
liver transplantationQ1368191
end-stage liver diseaseQ54974362
chronic hepatitisQ62019625
P304page(s)403-408
P577publication date2000-07-01
P1433published inJournal of Medical VirologyQ15716684
P1476titleEnd-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B.
P478volume61

Reverse relations

cites work (P2860)
Q34687438Chronic hepatitis B: current and future treatment options
Q44461529Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation
Q35110095Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature
Q33959006Management of viral hepatitis B.
Q35543577Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period
Q35156150Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease.
Q46712921Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis